The surgical robotics company's stock is up as sales open in the Korean market
By RBR Staff
June 13, 2012
In the wake of three successful robotic brain surgeries, Mazor Robotics Ltd., a developer of innovative surgical robots and complementary products, announced that its Korean distributor, BR Holdings, received marketing clearance from the Korean Food & Drug Administration (KFDA) to market Mazor’s Renaissance system. Bloomberg News also reported the company’s stock advanced 6.1% in intraday trading to 4.24 shekels, the highest level since May 17.
Renaissance is Mazor Robotics’ surgical guidance system for spine procedures. BR Holdings is a leading distributor of robotic surgery technologies and instruments in Korea.
It is typical for the local distributor to take responsibility for…
This is a preview article. Please register to view the entire article.